Wesper Journal

Rethinking Sleep Apnea: Dr. Atul Malhotra on Remote Patient Monitoring, Central Apnea, and the Future of GLP-1 Therapy

This in-depth interview with Dr. Atul Malhotra explores the clinical advantages of longitudinal sleep monitoring over single-night studies. The article covers emerging metrics like hypoxic burden, the importance of central sleep apnea detection, racial bias in pulse oximetry, and how GLP-1 therapies like tirzepatide are transforming obstructive sleep apnea treatment. Learn how Wesper’s airflow-based home testing platform delivers accurate, equitable, and evolving care for patients with sleep-disordered breathing.

An Injectable. A Pill. A Powerful Shift in Sleep Medicine.

This article explores how oral GLP-1 therapy, specifically Eli Lilly’s investigational pill orforglipron, may transform the treatment of obstructive sleep apnea (OSA) by targeting one of its primary root causes: obesity. It highlights clinical evidence from GLP-1 drugs like tirzepatide (Zepbound), which has already gained FDA approval for OSA, and examines how weight loss through these therapies significantly improves apnea severity. The article also outlines why the upcoming oral formulation is a game-changer, increasing accessibility and adherence for patients. With obesity, diabetes, and OSA deeply intertwined, GLP-1 therapy may soon play a central role in holistic sleep medicine.

What you need to know about GLP-1's for Obstructive Sleep Apnea

GLP-1 therapies, such as Zepbound (tirzepatide), address obstructive sleep apnea by aiding weight management, thereby reducing airway pressure and improving respiratory health. Wesper's wearable technology enhances treatment by providing continuous monitoring, allowing for timely adjustments to therapy plans. FDA’s Landmark...

Using GLP-1's and Wesper in Primary Care and why thats game changing

In primary care, the integration of GLP-1 medications and Wesper's sleep technology offers a holistic approach that improves patient outcomes by enhancing metabolic health and streamlining sleep disorder management. This synergy revolutionizes healthcare delivery, promoting efficient care coordination and personalized...

Why Is Wesper Poised to Change Sleep Medicine Alongside a GLP-1

Wesper is poised to change sleep medicine alongside GLP-1 by integrating advanced sleep monitoring technology with GLP-1 therapies, enabling comprehensive and personalized treatment for sleep apnea. This combination offers real-time treatment optimization and enhanced patient outcomes, marking a significant advancement...

1 2 3 Next

our research

The Wesper Journal is our weekly publication dedicated to exploring sleep apnea, sleep health, and the latest updates from Wesper. Each edition offers expert insights, practical tips, and valuable resources to help you better understand and improve your sleep, empowering you to take control of your sleep health journey.

Discover Our Research

The Wesper Journal is a weekly publication featuring expert insights, practical tips, and updates on sleep apnea and sleep health, empowering you to better understand and improve your sleep.